Mehdi Farokhnia, MD, MPH (he/him/his)

Staff Scientist, Assistant Professor
NIH, Johns Hopkins
Baltimore, United States

Dr. Mehdi Farokhnia is a physician-scientist at the National Institutes of Health (NIH) Intramural Research Program and an adjunct faculty at Johns Hopkins Bloomberg School of Public Health. His research focuses on understanding the neurobiology of addictive behaviors and identifying novel therapeutic targets for alcohol and other substance use disorders, with a particular focus on neuroendocrine pathways. Dr. Farokhnia uses a combination of behavioral, pharmacological, genetic, and neuroimaging methods and is interested in investigating innovative human laboratory approaches, as well as large-scale epidemiological methods, to facilitate the crosstalk between preclinical, clinical, and population-based addiction research. He is also interested in using big data to characterize biobehavioral substrates of health disparity (e.g., gender/sex and racial/ethnic differences) in risk/resilience to addiction and other mental health conditions.

Disclosure information not submitted.

Presentation(s):

• Receipt of glucagon-like peptide 1 receptor agonists is associated with reduced alcohol consumption: A retrospective propensity score-matched cohort study

  Monday, August 26, 2024
  2:45 PM – 3:00 PM CEST